 | • レポートコード：GIR-22F4725 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（2~3営業日） • 産業分類：化学＆材料 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global PEGylated Lipids Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界のペグ化脂質の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 ペグ化脂質市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・mPEG-DMPE、mPEG-DSPE、その他 アプリケーション別セグメントは次のように区分されます。 ・リポソーム封入（LNP）医薬品、その他 世界のペグ化脂質市場の主要な市場プレーヤーは以下のとおりです。 ・BroadPharm、NOF America、Merck、Jenkem、Avanti Polar Lipids、Lipoid 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、ペグ化脂質製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なペグ化脂質メーカーの企業概要、2019年～2022年までのペグ化脂質の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なペグ化脂質メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別ペグ化脂質の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのペグ化脂質のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのペグ化脂質市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびペグ化脂質の産業チェーンを掲載しています。 ・第13、14、15章では、ペグ化脂質の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - ペグ化脂質の概要 - タイプ別分析（2017年vs2021年vs2028年）：mPEG-DMPE、mPEG-DSPE、その他 - アプリケーション別分析（2017年vs2021年vs2028年）：リポソーム封入（LNP）医薬品、その他 - 世界のペグ化脂質市場規模・予測 - 世界のペグ化脂質生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - BroadPharm、NOF America、Merck、Jenkem、Avanti Polar Lipids、Lipoid ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：mPEG-DMPE、mPEG-DSPE、その他 ・アプリケーション別分析2017年-2028年：リポソーム封入（LNP）医薬品、その他 ・ペグ化脂質の北米市場分析 - ペグ化脂質の北米市場：タイプ別市場規模2017年-2028年 - ペグ化脂質の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・ペグ化脂質のヨーロッパ市場分析 - ：ペグ化脂質のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：ペグ化脂質のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・ペグ化脂質のアジア太平洋市場分析 - ペグ化脂質のアジア太平洋市場：タイプ別市場規模2017年-2028年 - ペグ化脂質のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・ペグ化脂質の南米市場分析 - ペグ化脂質の南米市場：タイプ別市場規模2017年-2028年 - ペグ化脂質の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・ペグ化脂質の中東・アフリカ市場分析 - ペグ化脂質の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - ペグ化脂質の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The PEGylated Lipids market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global PEGylated Lipids market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Liposome Encapsulated (LNP) Drugs accounting for % of the PEGylated Lipids global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While mPEG-DMPE segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of PEGylated Lipids include BroadPharm, NOF America, Merck, Jenkem, and Avanti Polar Lipids, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
PEGylated Lipids market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
mPEG-DMPE
mPEG-DSPE
Other
Market segment by Application can be divided into
Liposome Encapsulated (LNP) Drugs
Other
The key market players for global PEGylated Lipids market are listed below:
BroadPharm
NOF America
Merck
Jenkem
Avanti Polar Lipids
Lipoid
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe PEGylated Lipids product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of PEGylated Lipids, with price, sales, revenue and global market share of PEGylated Lipids from 2019 to 2022.
Chapter 3, the PEGylated Lipids competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PEGylated Lipids breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and PEGylated Lipids market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of PEGylated Lipids.
Chapter 13, 14, and 15, to describe PEGylated Lipids sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 PEGylated Lipids Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global PEGylated Lipids Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 mPEG-DMPE
1.2.3 mPEG-DSPE
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global PEGylated Lipids Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Liposome Encapsulated (LNP) Drugs
1.3.3 Other
1.4 Global PEGylated Lipids Market Size & Forecast
1.4.1 Global PEGylated Lipids Sales in Value (2017 & 2021 & 2028)
1.4.2 Global PEGylated Lipids Sales in Volume (2017-2028)
1.4.3 Global PEGylated Lipids Price (2017-2028)
1.5 Global PEGylated Lipids Production Capacity Analysis
1.5.1 Global PEGylated Lipids Total Production Capacity (2017-2028)
1.5.2 Global PEGylated Lipids Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 PEGylated Lipids Market Drivers
1.6.2 PEGylated Lipids Market Restraints
1.6.3 PEGylated Lipids Trends Analysis
2 Manufacturers Profiles
2.1 BroadPharm
2.1.1 BroadPharm Details
2.1.2 BroadPharm Major Business
2.1.3 BroadPharm PEGylated Lipids Product and Services
2.1.4 BroadPharm PEGylated Lipids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 NOF America
2.2.1 NOF America Details
2.2.2 NOF America Major Business
2.2.3 NOF America PEGylated Lipids Product and Services
2.2.4 NOF America PEGylated Lipids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck PEGylated Lipids Product and Services
2.3.4 Merck PEGylated Lipids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Jenkem
2.4.1 Jenkem Details
2.4.2 Jenkem Major Business
2.4.3 Jenkem PEGylated Lipids Product and Services
2.4.4 Jenkem PEGylated Lipids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Avanti Polar Lipids
2.5.1 Avanti Polar Lipids Details
2.5.2 Avanti Polar Lipids Major Business
2.5.3 Avanti Polar Lipids PEGylated Lipids Product and Services
2.5.4 Avanti Polar Lipids PEGylated Lipids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Lipoid
2.6.1 Lipoid Details
2.6.2 Lipoid Major Business
2.6.3 Lipoid PEGylated Lipids Product and Services
2.6.4 Lipoid PEGylated Lipids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 PEGylated Lipids Breakdown Data by Manufacturer
3.1 Global PEGylated Lipids Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global PEGylated Lipids Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in PEGylated Lipids
3.4 Market Concentration Rate
3.4.1 Top 3 PEGylated Lipids Manufacturer Market Share in 2021
3.4.2 Top 6 PEGylated Lipids Manufacturer Market Share in 2021
3.5 Global PEGylated Lipids Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and PEGylated Lipids Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global PEGylated Lipids Market Size by Region
4.1.1 Global PEGylated Lipids Sales in Volume by Region (2017-2028)
4.1.2 Global PEGylated Lipids Revenue by Region (2017-2028)
4.2 North America PEGylated Lipids Revenue (2017-2028)
4.3 Europe PEGylated Lipids Revenue (2017-2028)
4.4 Asia-Pacific PEGylated Lipids Revenue (2017-2028)
4.5 South America PEGylated Lipids Revenue (2017-2028)
4.6 Middle East and Africa PEGylated Lipids Revenue (2017-2028)
5 Market Segment by Type
5.1 Global PEGylated Lipids Sales in Volume by Type (2017-2028)
5.2 Global PEGylated Lipids Revenue by Type (2017-2028)
5.3 Global PEGylated Lipids Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global PEGylated Lipids Sales in Volume by Application (2017-2028)
6.2 Global PEGylated Lipids Revenue by Application (2017-2028)
6.3 Global PEGylated Lipids Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America PEGylated Lipids Sales by Type (2017-2028)
7.2 North America PEGylated Lipids Sales by Application (2017-2028)
7.3 North America PEGylated Lipids Market Size by Country
7.3.1 North America PEGylated Lipids Sales in Volume by Country (2017-2028)
7.3.2 North America PEGylated Lipids Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe PEGylated Lipids Sales by Type (2017-2028)
8.2 Europe PEGylated Lipids Sales by Application (2017-2028)
8.3 Europe PEGylated Lipids Market Size by Country
8.3.1 Europe PEGylated Lipids Sales in Volume by Country (2017-2028)
8.3.2 Europe PEGylated Lipids Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific PEGylated Lipids Sales by Type (2017-2028)
9.2 Asia-Pacific PEGylated Lipids Sales by Application (2017-2028)
9.3 Asia-Pacific PEGylated Lipids Market Size by Region
9.3.1 Asia-Pacific PEGylated Lipids Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific PEGylated Lipids Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America PEGylated Lipids Sales by Type (2017-2028)
10.2 South America PEGylated Lipids Sales by Application (2017-2028)
10.3 South America PEGylated Lipids Market Size by Country
10.3.1 South America PEGylated Lipids Sales in Volume by Country (2017-2028)
10.3.2 South America PEGylated Lipids Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa PEGylated Lipids Sales by Type (2017-2028)
11.2 Middle East & Africa PEGylated Lipids Sales by Application (2017-2028)
11.3 Middle East & Africa PEGylated Lipids Market Size by Country
11.3.1 Middle East & Africa PEGylated Lipids Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa PEGylated Lipids Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of PEGylated Lipids and Key Manufacturers
12.2 Manufacturing Costs Percentage of PEGylated Lipids
12.3 PEGylated Lipids Production Process
12.4 PEGylated Lipids Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 PEGylated Lipids Typical Distributors
13.3 PEGylated Lipids Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer